Amid calls for the entire exemption of goods and services tax (GST) on vaccines, Finance Minister Nirmala Sitharaman has said that a complete waiver may lead to a rise in their prices, impacting the common man.

While responding to West Bengal Chief Minister Mamata Banerjee's letter to the Prime Minister seeking support to improve the health infrastructure, along with removal of GST and customs duty from life-saving drugs and equipment, Sitharaman noted that vaccine makers would not be beneficiaries of input tax credit in case GST is exempted.

The Finance Minister was of the view that "If full exemption from GST is given, vaccine manufacturers would not be able to offset their input taxes and would pass them on to the end consumer/citizen by increasing the price,"  Also a nominal 5 per cent GST is in the interest of the domestic manufacturer of vaccine and in the interest of the citizens".

The minister noted that GST at rates varying from 5 per cent on vaccines to 12 per cent on Covid drugs and oxygen concentrators is applicable to domestic supplies and commercial import of these items. She also said that in order to augment the availability of these items, the government has also provided full exemption from basic customs duty and health cess to their commercial imports.

The FM noted that Covid vaccines are being provided free of cost by the Centre to those who are 45 years of age and above and to all frontline workers and on government supplies, GST is also paid by the government.

RBI allows re-opening of one-time restructuring individuals and MSMEs till Sept 30

Second threat of Covid-19 will dampen India Inc's recovery: ICRA Report

GDP Forecast: India's GDP may grow at 11 pc in FY22: Asian Dev Bank